Is exposure in vivo cost-effective for chronic low back pain? A trial-based economic evaluation.

Although EXP patients showed a larger improvement on disability and generic quality of life compared to GA patients, the difference did not reach statistical significance ( p > .30).

also in 111,027 other papers

The treatments did not differ significantly for functional disability, though the difference almost reached significance in favor of EXP.

also in 321 other papers